Abstract | Multiple sclerosis (MS) is typically considered to be a chronic inflammatory-demyelinating disease of CNS white matter. In the past decade, however, pathological and MRI studies have shown that lesions are often located in the gray matter, especially in the cerebral cortex. The histopathological characteristics of these cortical lesions differ substantially from lesions located in the white matter, which suggests location-dependent expression of the MS immunopathological process. Double inversion recovery imaging-an MRI technique that selectively images gray matter and lesions-has enabled researchers to image cortical lesions in vivo. Double inversion recovery studies have shown that cortical lesions can be detected at the earliest clinical stages of MS, and cortical lesion burden positively correlates with the severity of physical and cognitive impairments. These gray matter lesions are also independent predictors of subsequent disease evolution. This Review provides a summary of the main histopathological and MRI findings with regard to cortical lesions in MS, and indicates that increasing our understanding of cortical lesions has increased our knowledge of MS pathobiology.
Introduction
Multiple sclerosis (MS) is a chronic, debilitating disease of the CNS, characterized by multifocal areas of white matter inflammatory demyelination. For this reason, MS has traditionally been thought of as a 'pure' white matter disease. Nevertheless, since the first description of MS by Charcot, 1 this condition has been considered to be a multifaceted disorder, and lesions located in the sub cortical white matter have long been known to be associ ated with marked neurodegeneration of gray matter. 2, 3 Over the past 10-15 years, quantitative MRI studies have provided considerable evidence indicating that damage and atrophy of gray matter occurs at the earliest clini cal stages of the disease, [4] [5] [6] [7] [8] and evolves faster than white matter atrophy. 8 In addition, gray matter damage has been shown to correlate more closely with the degree of physical disability and cognitive impairment than do white matter lesion loads. [4] [5] [6] [9] [10] [11] [12] [13] A relatively good corre lation has also been observed between the severity of cortical inflammation and the rate of disease progres sion.
14 Whether gray matter degeneration is a conse quence of tissue destruction in the subcortical white matter, including axonal transection and retrograde neuro degeneration, 15 or is more dependent on local inflammation, has not yet been clarified.
Several postmortem and antemortem MRI studies have shown that a substantial proportion of focal MS lesions are located in the cerebral cortex, [16] [17] [18] [19] and double inversion recovery (DIR) MRI can detect more of these cortical lesions than standard MRI techniques. In this Review, we provide a summary of the main histopatho logical and MRI findings in relation to cortical lesions in MS, and discuss the clinical impact of these lesions on the daily activity of patients with this condition.
Pathology of cortical lesions
Numerous neuropathological studies have described the presence of focal lesions in the cortex and deep gray matter of patients with MS. In the early 1960s, Brownell and Hughes 20 showed that in brains from 22 indivi duals with MS, 26% of hemispheric lesions were located in brain areas outside the white matter, with 17% being located in the leucocortical junction, 4% in the central gray matter and 5% in the cortex. In a study of 60 patients with MS, Lumsden demonstrated that 93% of the study participants had cortical lesions: some of these patients only had a few focal lesions, but others were shown to have as many as 465 gyral plaques. 21 Similarly, Kidd and colleagues detected 478 cortical lesions in coronal sec tions taken from 12 MS brains, and showed that up to 76% of these lesions were located in the subcortical white matter. Furthermore, the researchers proposed that all cortical lesions can be categorized as one of seven dif ferent lesion types ( Table 1 ). The majority of the cortical lesions in the Kidd et al. study (75%) were located within the territory of the principal cortical veins, whereas the remaining lesions were situated either in the territory of the small branches of these veins or in the territory of the superficial veins. 16 This classification of the different lesion types was later simplified by Peterson et al. , who studied cortical lesions in 50 patients with MS. 17 Indeed, Peterson and colleagues identified only three types of cortical demyelination: type I lesions were contiguous with subcortical white matter lesions, type II lesions were small, confined to the cortex and often perivascular, and type III lesions extended from the pial surface to cortical layer 3 or 4.
The prevalence of cortical demyelination in MS has been confirmed in several other pathological studies, which all showed that cortical lesions are as numerous as white matter lesions in this disease. In a study of 20 patients with chronic MS, Bø et al. found that 84% of cor tical lesions were purely intracortical and accounted for 86% of the total area of cortical demyelination. 22 Moreover, the authors showed that ≈25% of the cortical area ana lyzed in the study was demyelinated, whereas only ≈5% of the total white matter was demyelinated. 22 The evolution of gray matter demyelination over time was illustrated in a study conducted by Kutzelnigg and colleagues. 23 using immuno histochemical tech niques, the researchers were able to show that demyelination of axons in the gray matter is already present in relapsing-remitting (RR) and acute MS, and becomes more prominent in chronic stages of the disease, such as secondary progressive (SP) and primary progressive MS. 23 These observations regarding cortical lesion evolution might explain why the extent of cortical patholo gy varies between studies. For example, vercellino et al. found that more than 90% of cortical lesions were restricted to the subpial layers of the cortex, and that ≈15% of the cortex was demyelinated compared with 21% of the white matter. 24 A classification based on four types of cortical lesion is now currently accepted (Table 1) . Type I lesions are those that extend through both the white matter and the gray matter, whereas type II lesions are entirely located within the cerebral cortex and do not make contact with the subcortical white matter or the pia mater and, in general, are small and perivascular. Type III lesions are subpial areas of demyelination, usually not extending beyond layers 3 and 4 of the cortex. By contrast, type Iv lesions extend over the entire width of the cortex, do not spread into the subcortical white matter, and might extend over several gyri or entire lobes. [16] [17] [18] 22 A marked regional variation in the amount of cortical demyelination has been observed. The most extensive damage occurs in the cingulate gyrus and in the temporal and frontal cortices. By contrast, the paracentral lobule, occipital lobe and primary motor cortex seem to be less severely affected. 22, 23, 25, 26 extensive demyelination is also evident in the hippocampus of patients with MS, and this prominent degeneration is associated with an appreci able decrease in hippocampal volume. 27, 28 The preferen tial distribution of cortical lesions in the hippocampus might indicate that brain areas that are constitutively active could be particularly susceptible to inflamma tory and/or neurodegenerative pathological processes. Indeed, hippocampal neurons are known to be extremely vulnerable to a variety of insults, including ischemia and inflammationinduced glutamatemediated excito toxicity. 29, 30 Further studies are required before we fully understand whether soluble neurotoxic factors released locally by inflammatory cells are involved in MSrelated neuronal degeneration.
Gray matter lesions in patients with MS have been proposed to be secondary phenomena that occur as a consequence of white matter lesion activity, which can cause extensive axonal damage, Wallerian degenera tion 15, 31 and neuronal loss. A histopathological study, 23 however, only demonstrated a marginal correlation between focal and diffuse white matter injury and corti cal pathology. This result suggests that three pathological processes could be taking place during disease progres sion: focal inflammatory demyelination of white matter, diffuse damage to the socalled normalappearing white matter and cortical demyelination. These three processes have been suggested to occur in parallel, possibly in an interdependent manner, as well as independently. 2, 23 The notion that gray matter demyelination can occur inde pendently from white matter demyelination is consistent with MRI studies that have demonstrated a dissociation between white matter lesion load and diffuse gray matter pathology. 2, 5, 6 The lack of substantial interdependence between white matter and gray matter damage does not seem to be a question of disease phase, since several MRI studies indicate that gray matter pathology is already evident at clinical onset of the disease, when white matter pathology is often very limited. 2, 5, 6, 32 Moreover, 'cortical onset' of MS has been observed in some patients. 33 Taken Not applicable reviews together, these findings suggest that at early time points gray matter demyelination and white matter demyeli nation proceed independently. 2, 3 By contrast, in more advanced phases of the disease, the accumulation of white matter lesions, which progresses more or less in a linear fashion, 32 could contribute to the dramatic increase in cortical pathology at these time points.
Cortical inflammation in MS
Although cortical lesions are welldemarcated areas of demyelination, characterized by substantial oligo dendrocyte and axonal loss, 17, 26 they differ markedly from white matter lesions in terms of the degree and type of inflammation. Indeed, pure intracortical lesions typically have a very low degree of inflammation. 17, 18, 22, 23 Furthermore, perivascular infiltrates are rarely found in the MS cortex, and the density of infiltrating lympho cytes in 'pure' cortical lesions is similar to the density of infiltrating lymphocytes in the normalappearing gray matter. Cortical lesions have been shown to contain 13fold fewer CD3 + lymphocytes and sixfold fewer CD68 + cells of the microglia-macrophage lineage than white matter lesions. 17 In the seminal paper by Bø et al., the re searchers showed that white matter lesions had the highest density of CD3 + T cells when compared with cortical lesions. 22 Interestingly, in the same study fewer T cells were detected in cortical lesions that extended through both white matter and gray matter than in 'pure' white matter lesions. More CD8 + cells than CD4 + cells were detected within both white matter lesions and cor tical lesions. Furthermore, CD8
+ and CD45RO + cells had similar distribution profiles to CD3 + cells-they were more frequently detected in white matter lesions than in cortical lesions. The numbers of CD8 + and CD45RO + cells were lower in cortical lesions than in non demyelinated white matter in MS brains and white matter from healthy controls. CD20 + B cells were rarely observed in any of the specimens examined.
These data indicate that areas of intracortical demyeli na tion in chronic MS are not associated with an increased number of lymphocytes, or an altered distribution of subsets of lymphocytes. Moreover, in 'pure' cortical lesions, no leakage of plasma proteins into the brain parenchyma has been detected, suggesting that normal blood-brain barrier function is maintained in these lesions. 34 Cortical lesions might occasionally contain deposits of C4d com plement protein in myelin and oligo dendrocytes, but no other appreciable signs of complement activation have been demonstrated. 35 In the cortical component of type I cortical lesions the density of infiltrating lymphocytes is lower than the infiltrating lymphocyte density observed in 'pure' white matter lesions, but is typically higher than the lymphocyte density detected in the cortex of healthy con trols. 17, 21 Taken together, these data indicate that cortical lesions and white matter lesions differ substantially in the pattern (number and subsets) of lymphocyte infiltration, and indicate that cortical demyeli nation might be partly independent of T cellmediated inflammation. 36 We must point out, however, that the tissue specimens analyzed in the studies were most probably representative of a chronic 'burntout' stage of plaque formation. 23 An analy sis of biopsy samples from newly diagnosed MS cases has demon strated that 'new' cortical lesions contain numer ous infiltrating immune cells, suggesting that the extent of lymphocyte infiltration in cortical lesions depends on the patient population studied. 2 In fact, cortical lesions can be readily differentiated into active or chronic lesions on the basis of the degree of inflammation. 17 A characteristic feature of cortical demyelination is the presence of activated microglia in the immediate vi cinity of cortical lesions, and the potential involvement of these cells in modulating local inflammation constitutes one of the most fascinating areas of research in MS. In fact, the majority of phagocytic cells in cortical lesions are described as having the morphology of activated microglia, whereas only a minority of these cells have a morphology associated with phagocytic macrophages. 17 Further more, cells derived from the monocyte-macrophage lineage are found at high densities at the edges of lesions, where extensive oligo dendrocyte injury occurs. 37 Activated microglia within cortical lesions contain elevated levels of myelo peroxidase, indicating that reactive oxygen species might contribute to tissue damage. 38 Considerable microglial activation-determined using immunological and biochemical markers-has been found in the brains of patients with MS, as well as in the cortex in patients with Alzheimer disease. The distributions of activated microglia were shown to be extremely similar in these two neuro degenerative diseases. 39 Nevertheless, the pres ence of activated microglia in the cortex in patients with MS, in contrast to the distribution of activated microglia observed in patients with Alzheimer disease, is corre lated with lymphocyte and plasma cell infiltration of the meninges. 39 Taken together, these findings suggest a detri mental (proinflammatory) rather than a neuro protective role for microglia in cortical MS pathology.
In summary, cortical lesions differ from white matter lesions in several quantitative and qualitative aspects of cellular inflammation, and by a lack of local blood-brain barrier dysfunction in cortical lesions compared with white matter lesions. Activated microglia also seem to have a more prominent role in cortical lesion pathology than they do in white matter pathology.
Meningeal inflammation in MS
The leptomeninges of patients with MS are known to harbor inflammatory infiltrates; 40 in fact, the first demon stration of a link between 'active' cortical lesions and menin geal inflammation dates back to 1975. 41 ecto pic B cell follicles have been found in the meninges of a substantial-although variable-percentage of brain specimens from patients with SPMS. [40] [41] [42] [43] However, the available data on the correlation between meningeal inflammation and cortical demyelination are conflict ing. In one study, the presence of ectopic B cell follicles in the leptomeninges positively correlated with the extent of gray matter demyelination, but did not correlate with the extent of white matter demyelination. All ectopic B cell follicles were found to be adjacent to subpial cor tical lesions, suggesting a central role for meningeal reviews B cell follicles in the pathogenesis of demyelination in these areas. 14 In another study, the potential associa tion between lepto meningeal inflammation and corti cal lesions was assessed in patients with chronic MS. 42 Analysis revealed that substantial meningeal inflamma tion was evident in these patients; however, no associ ation between meningeal inflammation and cortical demyelination was apparent. Furthermore, menin geal infiltrates taken from areas in close proxi mity to cor tical lesions were no different, with respect to cellular composition, from infiltrates taken from areas in close proximity to normalappearing gray matter. In addition, no folliclelike structures were observed in the menin geal infiltrates from the individuals participating in the study. 42 A role for the epstein-Barr virus (eBv) in meningeal and cortical inflammation has been suggested. Serafini et al. have found that eBv infection positively correlates with the presence of B cells, plasma cells and ectopic follicles in meningeal infiltrates of patients with MS. 44 An association between eBv and other inflammatory diseases of the CNS has not been established, indicat ing that eBv infection might selectively be involved in the manifestation of cortical lesion pathogenesis in MS. Cortical demyelination has also been suggested to be mediated through bystander mechanisms, as activated CD8 + T lymphocytes-with signs of cytotoxic reac tivity to plasma cells-have been detected in the brains of indivi duals with MS, and have been shown to positively correlate with the number of eBvinfected cells within the white matter and meninges. 44 These findings were not, however, confirmed by two other studies. 43, 45 The contradictory findings reported above do not allow any firm conclusions to be drawn on the possible relation ship between leptomeningeal inflammation and cortical demyelination. Therefore, the question of whether the initial inflammatory attack on the MS cortex comes from the cerebrospinal fluid (CSF) remains unresolved.
Detecting cortical lesions in vivo
Conventional and Dir imaging Conventional MRI techniques are generally poor at detecting cortical lesions and, as a result, relatively few studies have investigated the contribution of these lesions to MS pathobiology in vivo. Several factors hamper the identification of cortical lesions by means of con ventional T2 and fluid attenuated inversion recovery (FLAIR) MRI. For example, low levels of inflammatory cell infiltration 16 and the absence of substantial bloodbrain barrier damage in cortical lesions, 34 as well as low myelin density in upper cortical layers, all decrease the contrast of T2 MRI sequences. The partial volume effect resulting from the close proximity of cortical lesions to the CSF also deleteriously affects the contrast of T2 MRI sequences and makes the identification of cortical lesions by conventional MRI difficult.
examination of postmortem brain tissue by lowfield (1.5 T) FLAIR imaging has been shown to identify no more than 5-10% of all 'pure' intracortical lesions sub sequently detected histopathologically. 18 The capacity of conventional MRI techniques to identify cortical lesions depends on the lesion type. 46 For example, con ventional MRI detects <10% of type II, III and Iv corti cal lesions, 46 whereas mixed type I lesions are visualized relatively well by both standard and highfield MRI. 46 The readily observed white matter component of type I lesions undoubtedly facilitates visual detection of this type of injury, but the gray matter component of the lesion also seems to be more easily identified on MRI scans in type I lesions than in 'pure' cortical lesions. This observation might reflect the fact that deep corti cal layers have a higher myelin content than the more superficial layers of the cortex, and high myelin content increases T2 contrast. Type I lesions, including their gray matter component, have also been shown to have higher numbers of T lymphocytes and activated microglia than intracortical lesions. 46 The application of highfield MRI (9.4 T) has now improved the identification of subpial cortical lesions by conventional MRI. 47 using highfield MRI, Schmierer et al. showed that of 28 cortical lesions identified in motor cortex tissue specimens from patients with MS, 11 were subpial and 15 were mixed white and gray matter lesions, whereas only 2 extended across the whole width of the cerebral cortex. 47 The introduction of DIRbased MRI has substantially improved the in vivo detection of cortical lesions in patients with MS. 48 The exact anatomical border between the cortex and subcortical white matter can be difficult to determine on FLAIR images and, as a result, judging whether lesions are juxtacortical, mixed white and gray matter, or intracortical can be difficult. By contrast, by suppressing signals from white matter and CSF, DIR based imaging provides superior delineation of gray matter and increased lesion contrast in both gray matter and white matter. Consequently, cortical lesions are more readily detected by DIR imaging than by conventional imaging techniques (Figure 1) . utilization of DIR imaging has resulted in corti cal lesion detection rates per patient increasing by an average of 152% when compared with FLAIR imaging. More over, in comparison with conventional T2 MRI, DIR imaging has been shown to increase the detection of cortical lesions by an average of 500%. 48 We must point out, however, that a large proportion of cortical lesions remain undetected even when DIR imaging is used. In fact, DIR most probably only detects 10-20% of the cor tical lesions that are identified by immunohistological techniques. 18 Combining DIR with other MRI sequences, such as a T1weighted threedimensional (3D) spoiled gradientrecalled echo 49 and phasesensitive inversion recovery, 50 will, hopefully, increase the cortical lesion detection rate further. Currently, however, an optimal imaging technique that detects all cortical lesions is still lacking. Nevertheless, DIR sequences can be obtained relatively quickly and easily, and this convenience could potentially increase patient compliance. Furthermore, by employing 3D DIR imaging, a 3D reconstruction of the cerebral cortex can be obtained that provides a more detailed picture of cortical lesions than standard DIR imaging (Figure 2 ).
reviews An early and frequent phenomenon in Ms
In a DIR study of a large patient population, cortical lesions were detected in the majority of patients with RRMS (64%) and SPMS (70%), as well as in 37% of patients with clinically isolated syndrome. 19 This finding indicates that although cortical lesions are present in all MS phenotypes, the occurrence of cortical inflammation in this disease is an early phenomenon. Furthermore, patients with cortical lesions were shown to have higher expanded Disability Status Scale (eDSS) scores, a greater white matter T2 lesion load and a reduced brain volume than patients with MS who did not have cortical lesions. The number of cortical lesions correlated positively with eDSS score (P <0.001), white matter T2 lesion volume (P = 0.001), and brain volume (P = 0.001). A 3 year longitu dinal followup study demonstrated that the number and volume of cortical lesions increased over time at a sig nificantly greater rate in patients with MS with clinical worsen ing than in patients who were clinically stable. Baseline cortical lesion volume was also found to predict disability progression and gray matter atrophy at follow up. 51 In the same study, the accumulation rate of new cor tical lesions was shown to be similar in 76 patients with RRMS and 31 patients with SPMS (0.8 per year versus 1.0 per year), which suggests that the greater number of cortical lesions observed in patients with SPMS probably reflects the fact that patients with SPMS have had the disease over a longer period of time. These observations also suggest that the overall cortical lesion burden might affect disability progression in patients with MS.
Primary progressive and benign Ms
Cortical lesions have been observed in up to 80% of patients with primary progressive MS and have been shown to be positively correlated with disease duration, higher eDSS scores and increased cortical atrophy and disability. Cortical lesion volume at baseline is also an independent predictor of cortical gray matter atrophy and disability progression at followup. 52 Patients with benign MS-eDSS scores ≤3.0 at least 15 years after disease onset-have substantially fewer cortical lesions and smaller lesion volumes than patients with early RRMS who have a similar degree of dis ability but have had the disease for a shorter period of time. 53 Moreover, we have demonstrated that no substantial accumulation of cortical lesions was evident in patients with benign MS after 1 year of followup when compared with patients with early RRMS. 53 The same study revealed that cortical lesion number and volume at baseline and their changes over time are independent predictors of clini cal status. 53 These findings suggest that in patients with benign MS, the small number of cortical lesions might be associated with the favorable clinical status, indicating that when the cortical lesion load is small the capacity of the cortex to reorganize after tissue injury is still intact. 54 Cognitive dysfunction and epilepsy in Ms Cortical lesions might have a substantial impact on cog nitive function. Patients with RRMS who have cognitive defi cits have greater cortical lesion loads and cortical atrophy than patients with RRMS who do not have cog nitive deficits. 55 A multivariate analysis has revealed that cortical lesion volume and loss of neocortical volume are independent predictors of cognitive decline in these patients. 55 These results are in agreement with patho logical and imaging studies, 56, 57 which have also demon strated a significant reduction in cortical volume in patients with RRMS and cognitive impairment. By contrast, several reviews studies that have investigated the contribution of white matter damage to cognitive impairment in patients with MS have suggested that white matter lesion burden does not fully account for the severity of cognitive deficits, indi cating that cortical lesions might be the underlying cause of cognitive impairments in these patients. 57, 58 Patients with RRMS who have epileptic seizures seem more likely to have cortical lesions than patients who are seizure free. In fact, cortical lesions have been observed in 90% of patients with RRMS who experience seizures com pared with only 48% of nonepileptic patients (P = 0.001). 59 Cortical pathology was extensive in the patients who had RRMS and seizures; in fact, these patients had five times more cortical lesions than seizurefree individuals and had, on average, a total cortical lesion volume sixfold greater than the nonepileptic patients.
Conclusions
Histological and immunohistochemical studies indicate that demyelination of cortical gray matter is extensive in MS, and that cortical lesions represent a substantial pro portion of MS pathology. The cellular composition of cor tical lesions differs substantially from that of white matter lesions, suggesting locationdependent expression of the immunopathological process that is evident in MS.
DIR imaging results indicate that cortical lesions have a marked impact on disability progression in MS, and could occur, at least partially, independently of subcortical white matter pathology. Additional studies are required to further characterize the different types of cortical lesion, and to fully understand their formation. Longitudinal studies conducted on large cohorts of patients with MS are also needed to assess how cortical lesions correlate with other MRI parameters (for example, cortical atrophy), and to determine their contribution to disease evolu tion. Finally, the efficacy of diseasemodifying agents in preventing the accumulation of cortical lesions should be established.
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